Back to search

Article

A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif

2024-02-09

Abstract excerpt

The continuous emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants means there is a need to explore additional strategies to develop broad-spectrum vaccines or therapeutics for individuals remaining at risk of coronavirus disease 2019 (COVID-19). Neutralizing monoclonal antibody (mAb) that binds the conserved S2 subunit of the SARS-CoV-2 spike (S) protein alone, or in combination...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4723b260-49d4-50f7-8ad5-f5a83df61e10
DOI
10.1016/j.hlife.2024.02.001
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motifDOI 10.1016/j.hlife.2024.02.001
Select a neighboring publication to make it the new centre.